Jipmer to set up radio therapy ward to treat thyroid cancer

Jawaharlal institute of postgraduate medical education and research (Jipmer) is set to establish a comprehensive high dose radionuclide therapy ward to treat cancer patients, said Jipmer director S C Parija.

Inaugurating a two-day conference, 'Controversies and consensus in thyroid cancer', Parija said the proposed facility will treat six inpatients at a time. "It will be the largest such facility in South India and first of its kind in Puducherry. Apart from thyroid cancer the facility will also treat patients with other cancers like advanced neuroendocrine and prostate tumours," said Parija in a statement issued on May 4.

The department of surgical oncology, Jipmer organized the conference in association with Foundation of head and neck oncology, Indian association of surgical oncology and Indian society of thyroid surgeons. Director of Tata memorial hospital in Mumbai Anil D'Cruz performed a thyroid surgery, which was telecast live. D'Cruz, one of the leading head and neck surgeons in the country, explained the surgical procedure lucidly while he operated on the patient.

He also spoke on the global changes in the management of thyroid cancer and scenario prevailing in the country. More than 130 postgraduate students and consultants from various surgical fields attended the conference.

Thyroid cancer has a high cure rate if diagnosed early and treated appropriately. However there are a few areas in the disease where the experts have not yet come to a consensus in treating.



Popular posts from this blog

EMA Recommends Extension of Indications for Ramucirumab

Dr. Hootie Warren takes helm of Fred Hutch Global Oncology

Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate Combination of Opdivo (Nivolumab) and Rubraca® (Rucaparib) in Phase 2 and Pivotal Phase 3 Clinical Trials in Multiple Tumor Types